Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru


ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Лечебное дело
2021 / N 3

Урсодезоксихолевая кислота и COVID-19-ассоциированное поражение печени
Л.Ю. Ильченко, И.Г. Никитин, И.Г. Федоров, Г.Г. Тотолян

Список литературы

1. Coronavirus Resource Center. COVID-19 dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). Available from: https://coronavirus.jhu.edu/map.html Accessed 2021 Oct 18.
2. Guarner J. Three emerging coronaviruses in two decades: the story of SARS, MERS, and now COVID-19. American Journal of Clinical Pathology 2020 Mar;153(4):420-1.
3. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, Bi Y, Ma X, Zhan F, Wang L, Hu T, Zhou H, Hu Z, Zhou W, Zhao L, Chen J, Meng Y, Wang J, Lin Y, Yuan J, Xie Z, Ma J, Liu WL, Wang D, Xu W, Holmes EC, Gao GF, Wu G, Chen W, Shi W, Tan W. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet 2020 Feb;395(10224):565-74.
4. Chen N, Zhou N, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet 2020 Feb;395(10223):507-13.
5. Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. Journal of Pharmaceutical Analysis 2020 Apr;10(2):102-8.
6. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of Autoimmunity 2020 May;109:102433.
7. Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu S, Zhao P, Liu H, Zhu L, Tai Y, Bai C, Gao T, Song J, Xia P, Dong J, Zhao J, Wang FS. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet. Respiratory Medicine 2020 Apr;8(4):420-2.
8. Tai W, He L, Zhang X, Pu J, Voronin D, Jiang S, Zhou Y, Du L. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cellular & Molecular Immunology 2020 Jun;17(6):613-20.
9. Liu W, Li H. COVID-19: attacks the 1-beta chain of hemoglobin and captures the porphyrin to inhibit human heme metabolism. 2020. Available from: https://chemrxiv.org/engage/chemrxiv/article-details/6142e0d5b817b45fbb1e9b19 Accessed 2021 Oct 18.
10. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ; HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet 2020 Mar;395(10229):1033-4.
11. Arachchillage DRJ, Laffan M. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. Journal of Thrombosis and Haemostasis 2020 May;18(5):1233-4.
12. Barth RF, Xu X, Buja LM. A call to action: the need for autopsies to determine the full extent of organ involvement associated with COVID-19. Chest 2020 Jul;158(1):43-4.
13. Hanley B, Lucas SB, Youd E, Swift B, Osborn M. Autopsy in suspected COVID-19 cases. Journal of Clinical Pathology 2020 May;73(5):239-42.
14. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19). China CDC Weekly 2020;2:113-22. Available from: http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51 Accessed 2021 Oct 18.
15. Sorbello M, El-Boghdadly K, Di Giacinto I, Cataldo R, Esposito C, Falcetta S, Merli G, Cortese G, Corso RM, Bressan F, Pintaudi S, Greif R, Donati A, Petrini F; Società Italiana di Anestesia Analgesia Rianimazione e Terapia Intensiva (SIAARTI) Airway Research Group; The European Airway Management Society. The Italian coronavirus disease 2019 outbreak: recommendations from clinical practice. Anaesthesia 2020 Jun;75(6):724-32.
16. Министерство здравоохранения РФ. Временные методические рекомендации. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Версии 1–12 (2020–2021).
17. Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, Tan KS, Wang DY, Yan Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Military Medical Research 2020 Mar;7(1):11.
18. Министерство здравоохранения РФ. Отчет о совместной технической миссии ВОЗ и Китайской Народной Республики (КНР) по проблеме новой короновирусной инфекции COVID-2019. Доступно по: https://minzdrav.gov.ru/news/2020/03/03/13469-predstavlen-otchet-o-rabote-mezhdunarodnoy-missii-voz-po-probleme-covid-19 Ссылка активна на 19.10.2021.
19. Chow EJ, Schwartz NG, Tobolowsky FA, Zacks RLT, Huntington-Frazier M, Reddy SC, Rao AK. Symptom screening at illness onset of health care personnel with SARS-CoV-2 infection in King County, Washington. JAMA 2020 May;323(20):2087-9.
20. Eliezer M, Hautefort C, Hamel AL, Verillaud B, Herman P, Houdart E, Eloit C. Sudden and complete olfactory loss function as a possible symptom of COVID-19. JAMA Otolaryngology – Head & Neck Surgery 2020 Jul;146(7):674-5.
21. Xydakis MS, Dehgani-Mobaraki P, Holbrook EH, Geisthoff UW, Bauer C, Hautefort C, Herman P, Manley GT, Lyon DM, Hopkins C. Smell and taste dysfunction in patients with COVID-19. The Lancet. Infectious Diseases 2020 Sep;20(9):1015-6.
22. Oxley TJ, Mocco J, Majidi S, Kellner CP, Shoirah H, Singh IP, De Leacy RA, Shigematsu T, Ladner TR, Yaeger KA, Skliut M, Weinberger J, Dangayach NS, Bederson JB, Tuhrim S, Fifi JT. Large-vessel stroke as a presenting feature of Covid-19 in the young. The New England Journal of Medicine 2020 May;382(20):e60.
23. Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, Collange O, Boulay C, Fafi-Kremer S, Ohana M, Anheim M, Meziani F. Neurologic features in severe SARS-CoV-2 infection. The New England Journal of Medicine 2020 Jun;382(23):2268-70.
24. Cheema M, Aghazadeh H, Nazarali S, Ting A, Hodges J, McFarlane A, Kanji JN, Zelyas N, Damji KF, Solarte C. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19). Canadian Journal of Ophthalmology 2020 Aug;55(4):e125-9.
25. Kim D, Quinn J, Pinsky B, Shah NH, Brown I. Rates of co-infection between SARS-CoV-2 and other respiratory pathogens. JAMA 2020 May;323(20):2085-6.
26. Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. Journal of the European Academy of Dermatology and Venereology 2020 May;34(5):e212-3.
27. Casas СG, Català A, Hernández GC, Rodríguez-Jiménez P, Fernández-Nieto D, Rodríguez-Villa Lario A, Navarro Fernández I, Ruiz-Villaverde R, Falkenhain-López D, Llamas Velasco M, García-Gavín J, Baniandrés O, González-Cruz C, Morillas-Lahuerta V, Cubiró X, Figueras Nart I, Selda-Enriquez G, Romaní J, Fustà-Novell X, Melian-Olivera A, Roncero Riesco M, Burgos-Blasco P, Sola Ortigosa J, Feito Rodriguez M, García-Doval I. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. The British Journal of Dermatology 2020 Jul;183(1):71-7.
28. Alramthan A, Aldaraji W. Two cases of COVID-19 presenting with a clinical picture resembling chilblains: first report from the Middle East. Clinical and Experimental Dermatology 2020 Aug;45(6):746-8.
29. Лучевая диагностика коронавирусной болезни (COVID-19): организация, методология, интерпретация результатов. Методические рекомендации. М.: НПКЦ ДиТ ДЗМ; 2020. 82 с.
30. Lippi G, Favaloro EJ. D-dimer is associated with severity of coronavirus disease 2019: a pooled analysis. Thrombosis and Haemostasis 2020 May;120(5):876-8.
31. Xu L, Liu J, Lu M, Yang D, Zheng X. Liver injury during highly pathogenic human coronavirus infections. Liver International 2020 May;40(5):998-1004.
32. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical characteristics of 2019 novel coronavirus infection in China. The New England Journal of Medicine 2020 Apr;382(18):1708-20.
33. Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. The Lancet. Gastroenterology & Hepatology 2020 May;5(5):428-30.
34. Young BE, Ong SWX, Kalimuddin S, Low JG, Tan SY, Loh J, Ng OT, Marimuthu K, Ang LW, Mak TM, Lau SK, Anderson DE, Chan KS, Tan TY, Ng TY, Cui L, Said Z, Kurupatham L, Chen MIC, Chan M, Vasoo S, Wang LF, Tan BH, Lin RTP, Lee VJM, Leo YS, Lye DC; Singapore 2019 Novel Coronavirus Outbreak Research Team. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA 2020 Apr;323(15):1488-94.
35. Cholankeril G, Podboy A, Aivaliotis VI, Tarlow B, Pham EA, Spencer SP, Kim D, Hsing A, Ahmed A. High prevalence of concurrent gastrointestinal manifestations in patients with severe acute respiratory syndrome coronavirus 2: early experience from California. Gastroenterology 2020 Aug;159(2):775-7.
36. Lin L, Jiang X, Zhang Z, Huang S, Zhang Z, Fang Z, Gu Z, Gao L, Shi H, Mai L, Liu Y, Lin X, Lai R, Yan Z, Li X, Shan H. Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection. Gut 2020 Jun;69(6):997-1001.
37. Wu Y, Guo C, Tang L, Hong Z, Zhou J, Dong X, Yin H, Xiao Q, Tang Y, Qu X, Kuang L, Fang X, Mishra N, Lu J, Shan H, Jiang G, Huang X. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. The Lancet. Gastroenterology and Hepatology 2020 May;5(5):434-5.
38. Gu J, Han B, Wang J. COVID-19: gastrointestinal manifestations and potential fecal-oraltransmission. Gastroenterology 2020 May;158(6):1518-9.
39. Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology 2020 May;158(6):1831-3.e3.
40. Wander P, Epstein M, Bernstein D. COVID-19 presenting as acute hepatitis. The American Journal of Gastroenterology 2020 Jun;115(6):941-2.
41. Boettler T, Newsome PN, Mondelli MU, Maticic M, Cordero E, Cornberg M, Berg T. Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper, JHEP Reports: Innovation in Hepatology 2020 Jun;2(3):100113.
42. Lleo A, Invernizzi P, Lohse AW, Aghemo A, Carbone M. Highlights for management of patients with autoimmune liver disease during COVID-19 pandemia. Journal of Hepatology 2020 Aug;73(2):453-5.
43. Ji D, Qin E, Xu J, Zhang D, Cheng G, Wang Y, Lau G. Non-alcoholic fatty liver diseases in patients with COVID-19: a retrospective study. Journal of Hepatology 2020 Aug;73(2):451-3.
44. Tapper EB, Asrani SK. The COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care. Journal of Hepatology 2020 Aug;73(2):441-5.
45. Saigal S, Gupta S, Sudhindran S, Goyal N, Rastogi A, Jacob M, Raja K, Ramamurthy A, Asthana S, Dhiman RK, Singh B, Perumalla R, Malik A, Shanmugham N, Soin AS. Liver transplantation and COVID-19 (Coronavirus) infection: guidelines of the Liver Transplant Society of India (LTSI). Hepatology International 2020 Jul;14(4):429-31.
46. Bhimraj A, Morgan RL, Shumaker AH, Lavergne V, Baden L, Cheng VCC, Edwards KM, Gandhi R, Muller WJ, O’Horo JC, Shoham S, Murad MH, Mustafa RA, Sultan S, Falck-Ytter Y. Infectious Diseases Society of America Guidelines on the treatment and management of patients with COVID-19. Clinical Infectious Diseases 2020 Apr 27;ciaa478.
47. Falcão MB, de Góes Cavalcanti LP, Filho NMF, de Brito CAA. Case report: hepatotoxicity associated with the use of hydroxychloroquine in a patient with COVID-19. The American Journal of Tropical Medicine and Hygiene 2020 Jun;102(6):1214-6.
48. Sunkara B, Roofeh D, Silver S, LeBleu Pearson T, Ettel M, McCune WJ. The devil’s in the dosing: severe drug-induced liver injury in a hydroxychloroquine-naive patient with subacute cutaneous lupus erythematosus and porphyria cutanea tarda. Lupus 2018 Jul;27(8):1383-6.
49. Makin AJ, Wendon J, Fitt S, Portmann BC, Williams R. Fulminant hepatic failure secondary to hydroxychloroquine. Gut 1994 Apr;35(4):569-70.
50. Wei CH, Penunuri A, Karpouzas G, Fleishman W, Datta A, French SW. Troxis necrosis, a novel mechanism for drug-induced hepatitis secondary to immunomodulatory therapy. Experimental and Molecular Pathology 2015 Oct;99(2):341-3.
51. van den Broek MPH, Möhlmann JE, Abeln BGS, Liebregts M, van Dijk VF, van de Garde EMW. Chloroquine-induced QTc prolongation in COVID-19 patients. Netherlands Heart Journal 2020 Jul;28(7-8):406-9.
52. COVID-19 Drug Interactions. Evaluating the drug-drug interaction risk of experimental COVID-19 therapies. Available from: https://www.covid19-druginteractions.org Accessed 2021 Oct 18.
53. Федеральный закон от 21 ноября 2011 г. № 323-ФЗ «Об основах охраны здоровья граждан в Российской Федерации». Доступно по: https://minzdrav.gov.ru/documents/7025. Ссылка активна на 08.11.2021.
54. Алыева А., Никитин И., Архипов А. Сопроводительная терапия острого лекарственного повреждения печени на фоне химиотерапевтического лечения у пациенток с раком молочной железы. Лечебное дело 2018;2:74-84.
55. Khorsavi M. Ursodeoxycholic acid in patients with treatment-resistant schizophrenia suffering from coronavirus disease: a hypothesis letter. Frontiers in Psychiatry 2021 Apr; 12:657316.
56. Yadav R, Chondhury Ch, Kumar Y. Virtual repurposing of ursodeoxycholate and chenodeoxycholate as lead candidates against Sars-Cov-2-Envelope protein: a molecular dynamics investigation. Journal of Biomolecular Structure and Dynamics 2020 Dec;2:1-12.
57. Cichoż-Lach H, Michalak A. Liver injury in the era of COVID-19. World Journal of Gastroenterology 2021 Feb;27(5):377-90.
58. Ursodeoxycholic acid. Available from: https://go.drugbank.com/drugs/DB01586 Accessed 2021 Oct 18.

References

1. Coronavirus Resource Center. COVID-19 dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). Available from: https://coronavirus.jhu.edu/map.html Accessed 2021 Oct 18.
2. Guarner J. Three emerging coronaviruses in two decades: the story of SARS, MERS, and now COVID-19. American Journal of Clinical Pathology 2020 Mar;153(4):420-1.
3. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, Bi Y, Ma X, Zhan F, Wang L, Hu T, Zhou H, Hu Z, Zhou W, Zhao L, Chen J, Meng Y, Wang J, Lin Y, Yuan J, Xie Z, Ma J, Liu WL, Wang D, Xu W, Holmes EC, Gao GF, Wu G, Chen W, Shi W, Tan W. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet 2020 Feb;395(10224):565-74.
4. Chen N, Zhou N, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet 2020 Feb;395(10223):507-13.
5. Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. Journal of Pharmaceutical Analysis 2020 Apr;10(2):102-8.
6. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of Autoimmunity 2020 May;109:102433.
7. Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu S, Zhao P, Liu H, Zhu L, Tai Y, Bai C, Gao T, Song J, Xia P, Dong J, Zhao J, Wang FS. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet. Respiratory Medicine 2020 Apr;8(4):420-2.
8. Tai W, He L, Zhang X, Pu J, Voronin D, Jiang S, Zhou Y, Du L. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cellular & Molecular Immunology 2020 Jun;17(6):613-20.
9. Liu W, Li H. COVID-19: attacks the 1-beta chain of hemoglobin and captures the porphyrin to inhibit human heme metabolism. 2020. Available from: https://chemrxiv.org/engage/chemrxiv/article-details/6142e0d5b817b45fbb1e9b19 Accessed 2021 Oct 19.
10. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ; HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet 2020 Mar;395(10229):1033-4.
11. Arachchillage DRJ, Laffan M. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. Journal of Thrombosis and Haemostasis 2020 May;18(5):1233-4.
12. Barth RF, Xu X, Buja LM. A call to action: the need for autopsies to determine the full extent of organ involvement associated with COVID-19. Chest 2020 Jul;158(1):43-4.
13. Hanley B, Lucas SB, Youd E, Swift B, Osborn M. Autopsy in suspected COVID-19 cases. Journal of Clinical Pathology 2020 May;73(5):239-42.
14. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19). China CDC Weekly 2020;2:113-22. Available from: http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51 Accessed 2021 Oct 19.
15. Sorbello M, El-Boghdadly K, Di Giacinto I, Cataldo R, Esposito C, Falcetta S, Merli G, Cortese G, Corso RM, Bressan F, Pintaudi S, Greif R, Donati A, Petrini F; Società Italiana di Anestesia Analgesia Rianimazione e Terapia Intensiva (SIAARTI) Airway Research Group; The European Airway Management Society. The Italian coronavirus disease 2019 outbreak: recommendations from clinical practice. Anaesthesia 2020 Jun;75(6):724-32.
16. Ministry of Health of the Russian Federation. Temporary methodological recommendations. Prevention, diagnosis, and treatment of a new coronavirus infection (COVID-19). Versions 1–12 (2020–2021). (In Russian).
17. Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, Tan KS, Wang DY, Yan Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Military Medical Research 2020 Mar;7(1):11.
18. Ministry of Health of the Russian Federation. Report on the joint technical mission of WHO and the People’s Republic of China (PRC) on the problem of a new coronavirus infection COVID-2019. Available from: https://minzdrav.gov.ru/news/2020/03/03/13469-predstavlen-otchet-o-rabote-mezhdunarodnoy-missii-voz-po-probleme-covid-19 Accessed 2021 Oct 19 (In Russian).
19. Chow EJ, Schwartz NG, Tobolowsky FA, Zacks RLT, Huntington-Frazier M, Reddy SC, Rao AK. Symptom screening at illness onset of health care personnel with SARS-CoV-2 infection in King County, Washington. JAMA 2020 May;323(20):2087-9.
20. Eliezer M, Hautefort C, Hamel AL, Verillaud B, Herman P, Houdart E, Eloit C. Sudden and complete olfactory loss function as a possible symptom of COVID-19. JAMA Otolaryngology – Head & Neck Surgery 2020 Jul;146(7):674-5.
21. Xydakis MS, Dehgani-Mobaraki P, Holbrook EH, Geisthoff UW, Bauer C, Hautefort C, Herman P, Manley GT, Lyon DM, Hopkins C. Smell and taste dysfunction in patients with COVID-19. The Lancet. Infectious Diseases 2020 Sep;20(9):1015-6.
22. Oxley TJ, Mocco J, Majidi S, Kellner CP, Shoirah H, Singh IP, De Leacy RA, Shigematsu T, Ladner TR, Yaeger KA, Skliut M, Weinberger J, Dangayach NS, Bederson JB, Tuhrim S, Fifi JT. Large-vessel stroke as a presenting feature of Covid-19 in the young. The New England Journal of Medicine 2020 May;382(20):e60.
23. Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, Collange O, Boulay C, Fafi-Kremer S, Ohana M, Anheim M, Meziani F. Neurologic features in severe SARS-CoV-2 infection. The New England Journal of Medicine 2020 Jun;382(23):2268-70.
24. Cheema M, Aghazadeh H, Nazarali S, Ting A, Hodges J, McFarlane A, Kanji JN, Zelyas N, Damji KF, Solarte C. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19). Canadian Journal of Ophthalmology 2020 Aug;55(4):e125-9.
25. Kim D, Quinn J, Pinsky B, Shah NH, Brown I. Rates of co-infection between SARS-CoV-2 and other respiratory pathogens. JAMA 2020 May;323(20):2085-6.
26. Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. Journal of the European Academy of Dermatology and Venereology 2020 May;34(5):e212-3.
27. Casas СG, Català A, Hernández GC, Rodríguez-Jiménez P, Fernández-Nieto D, Rodríguez-Villa Lario A, Navarro Fernández I, Ruiz-Villaverde R, Falkenhain-López D, Llamas Velasco M, García-Gavín J, Baniandrés O, González-Cruz C, Morillas-Lahuerta V, Cubiró X, Figueras Nart I, Selda-Enriquez G, Romaní J, Fustà-Novell X, Melian-Olivera A, Roncero Riesco M, Burgos-Blasco P, Sola Ortigosa J, Feito Rodriguez M, García-Doval I. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. The British Journal of Dermatology 2020 Jul;183(1):71-7.
28. Alramthan A, Aldaraji W. Two cases of COVID-19 presenting with a clinical picture resembling chilblains: first report from the Middle East. Clinical and Experimental Dermatology 2020 Aug;45(6):746-8.
29. Radiation diagnostics of coronavirus disease (COVID-19): organization, methodology, interpretation of results. Methodological recommendations. Moscow: Scientific and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Department of Health; 2020. 82 p. (In Russian).
30. Lippi G, Favaloro EJ. D-dimer is associated with severity of coronavirus disease 2019: a pooled analysis. Thrombosis and Haemostasis 2020 May;120(5):876-8.
31. Xu L, Liu J, Lu M, Yang D, Zheng X. Liver injury during highly pathogenic human coronavirus infections. Liver International 2020 May;40(5):998-1004.
32. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical characteristics of 2019 novel coronavirus infection in China. The New England Journal of Medicine 2020 Apr;382(18):1708-20.
33. Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. The Lancet. Gastroenterology & Hepatology 2020 May;5(5):428-30.
34. Young BE, Ong SWX, Kalimuddin S, Low JG, Tan SY, Loh J, Ng OT, Marimuthu K, Ang LW, Mak TM, Lau SK, Anderson DE, Chan KS, Tan TY, Ng TY, Cui L, Said Z, Kurupatham L, Chen MIC, Chan M, Vasoo S, Wang LF, Tan BH, Lin RTP, Lee VJM, Leo YS, Lye DC; Singapore 2019 Novel Coronavirus Outbreak Research Team. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA 2020 Apr;323(15):1488-94.
35. Cholankeril G, Podboy A, Aivaliotis VI, Tarlow B, Pham EA, Spencer SP, Kim D, Hsing A, Ahmed A. High prevalence of concurrent gastrointestinal manifestations in patients with severe acute respiratory syndrome coronavirus 2: early experience from California. Gastroenterology 2020 Aug;159(2):775-7.
36. Lin L, Jiang X, Zhang Z, Huang S, Zhang Z, Fang Z, Gu Z, Gao L, Shi H, Mai L, Liu Y, Lin X, Lai R, Yan Z, Li X, Shan H. Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection. Gut 2020 Jun;69(6):997-1001.
37. Wu Y, Guo C, Tang L, Hong Z, Zhou J, Dong X, Yin H, Xiao Q, Tang Y, Qu X, Kuang L, Fang X, Mishra N, Lu J, Shan H, Jiang G, Huang X. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. The Lancet. Gastroenterology and Hepatology 2020 May;5(5):434-5.
38. Gu J, Han B, Wang J. COVID-19: gastrointestinal manifestations and potential fecal-oraltransmission. Gastroentуrology 2020 May;158(6):1518-9.
39. Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology 2020 May;158(6):1831-3.e3.
40. Wander P, Epstein M, Bernstein D. COVID-19 presenting as acute hepatitis. The American Journal of Gastroenterology 2020 Jun;115(6):941-2.
41. Boettler T, Newsome PN, Mondelli MU, Maticic M, Cordero E, Cornberg M, Berg T. Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper, JHEP Reports: Innovation in Hepatology 2020 Jun;2(3):100113.
42. Lleo A, Invernizzi P, Lohse AW, Aghemo A, Carbone M. Highlights for management of patients with autoimmune liver disease during COVID-19 pandemia. Journal of Hepatology 2020 Aug;73(2):453-5.
43. Ji D, Qin E, Xu J, Zhang D, Cheng G, Wang Y, Lau G. Non-alcoholic fatty liver diseases in patients with COVID-19: a retrospective study. Journal of Hepatology 2020 Aug;73(2):451-3.
44. Tapper EB, Asrani SK. The COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care. Journal of Hepatology 2020 Aug;73(2):441-5.
45. Saigal S, Gupta S, Sudhindran S, Goyal N, Rastogi A, Jacob M, Raja K, Ramamurthy A, Asthana S, Dhiman RK, Singh B, Perumalla R, Malik A, Shanmugham N, Soin AS. Liver transplantation and COVID-19 (Coronavirus) infection: guidelines of the Liver Transplant Society of India (LTSI). Hepatology International 2020 Jul;14(4):429-31.
46. Bhimraj A, Morgan RL, Shumaker AH, Lavergne V, Baden L, Cheng VCC, Edwards KM, Gandhi R, Muller WJ, O’Horo JC, Shoham S, Murad MH, Mustafa RA, Sultan S, Falck-Ytter Y. Infectious Diseases Society of America Guidelines on the treatment and management of patients with COVID-19. Clinical Infectious Diseases 2020 Apr 27;ciaa478. doi: 10.1093/cid/ciaa478. Online ahead of print.
47. Falcão MB, de Góes Cavalcanti LP, Filho NMF, de Brito CAA. Case report: hepatotoxicity associated with the use of hydroxychloroquine in a patient with COVID-19. The American Journal of Tropical Medicine and Hygiene 2020 Jun;102(6):1214-6.
48. Sunkara B, Roofeh D, Silver S, LeBleu Pearson T, Ettel M, McCune WJ. The devil’s in the dosing: severe drug-induced liver injury in a hydroxychloroquine-naive patient with subacute cutaneous lupus erythematosus and porphyria cutanea tarda. Lupus 2018 Jul;27(8):1383-6.
49. Makin AJ, Wendon J, Fitt S, Portmann BC, Williams R. Fulminant hepatic failure secondary to hydroxychloroquine. Gut 1994 Apr;35(4):569-70.
50. Wei CH, Penunuri A, Karpouzas G, Fleishman W, Datta A, French SW. Troxis necrosis, a novel mechanism for drug-induced hepatitis secondary to immunomodulatory therapy. Experimental and Molecular Pathology 2015 Oct;99(2):341-3.
51. van den Broek MPH, Möhlmann JE, Abeln BGS, Liebregts M, van Dijk VF, van de Garde EMW. Chloroquine-induced QTc prolongation in COVID-19 patients. Netherlands Heart Journal 2020 Jul;28(7-8):406-9.
52. COVID-19 Drug Interactions. Evaluating the drug-drug interaction risk of experimental COVID-19 therapies. Available from: https://www.covid19-druginteractions.org Accessed 2021 Oct 18.
53. Federal Law No. 323-FZ of November 21, 2011 «About bases of public health protection in the Russian Federation». Available from: https://minzdrav.gov.ru/documents/7025 Accessed 2021 Nov 08. (In Russian).
54. Alyeva A, Nikitin I, Arkhipov A. The treatment of acute hemotherapy: induced liver injury in women with breast cancer. Lechebnoye Delo 2018;2:74-84 (In Russian).
55. Khorsavi M. Ursodeoxycholic acid in patients with treatment-resistant schizophrenia suffering from coronavirus disease: a hypothesis letter. Frontiers in Psychiatry 2021 Apr; 12:657316.
56. Yadav R, Chondhury Ch, Kumar Y. Virtual repurposing of ursodeoxycholate and chenodeoxycholate as lead candidates against Sars-Cov-2-Envelope protein: a molecular dynamics investigation. Journal of Biomolecular Structure and Dynamics 2020 Dec;2:1-12.
57. Cichoż-Lach H, Michalak A. Liver injury in the era of COVID-19. World Journal of Gastroenterology 2021 Feb;27(5):377-90.
58. Ursodeoxycholic acid. Available from: https://go.drugbank.com/drugs/DB01586 Accessed 2021 Oct 18.
  

[ Содержание выпуска N 3 | Выпуски журнала | Список журналов ]